TREE NEWS reports: US stocks opened mixed, with the Dow down 0.13%, the S&P 500 up 0.08% and the Nasdaq up 0.13%. Intel fell nearly 3%, while TSMC rose more than 1% after reports it is in talks with Elon Musk’s Terafab over a potential collaboration. Vaxcyte surged 53% after its pneumococcal vaccine met late-stage clinical trial goals.
US Stocks Open Mixed; TSMC Up 1% on Reported Musk Terafab Talks
The reported Terafab talks matter less as a headline than as a signal of where advanced chip capacity demand is heading, and TSMC's modest gain suggests the market is treating it as optionality rather than a done deal. Intel's steeper decline alongside that news hints at continued competitive pressure on foundry positioning. The outsized Vaxcyte move is a reminder that single-name clinical catalysts can dwarf index-level moves on a mixed open. Whether the Terafab discussions progress, and how Intel responds, is the open question worth tracking.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.